3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
25
Multiple Myeloma
13
Prostatic Neoplasms
10
Osteoporosis
8
Neoplasm Metastasis
8
Carcinoma, Non-Small-Cell Lung
5
Fractures, Bone
4
Neoplasms, Plasma Cell
3
Lymphoma
3
Bone Diseases, Metabolic
3
Bone Diseases
3
Spinal Cord Compression
2
Pain
2
Ovarian Neoplasms
2
Osteosarcoma
2
Lung Neoplasms
2
Kidney Neoplasms
2
Hematologic Neoplasms
2
Carcinoma, Renal Cell
2
Bone Neoplasms
2
Uterine Cervical Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Pleural Effusion, Malignant
1
Paraproteinemias
1
Oligodendroglioma
1
Neoplastic Processes
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Nasopharyngeal Neoplasms
1
Interventions
antineoplaston AS 2-1
3
antineoplaston A10
3
dactolisib
2
Temozolomide
2
Irinotecan
2
Everolimus
2
Bevacizumab
2
surufatinib
1
spartalizumab
1
poly ICLC
1
plerixafor
1
pasireotide
1
fosbretabulin
1
cixutumumab
1
adavosertib
1
Vaccines
1
TH 302
1
Sunitinib
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Radiation
1
PM 00104
1
Lapatinib
1
Immunologic Techniques
1
Immunoglobulin G
1
Genistein
1
Fentanyl
1
Donepezil
1
Disulfides
1
Decitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neuroectodermal Tumors, Primitive
×
Zoledronic Acid
×
Clear all
No trials found.